Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2005

VistaGen Therapeutics (VSTA) Awarded $3,700,000 NIH Drug Development Grant for LeadEpilepsy Drug Candidate

Burlingame, CA, May 24, 2005 /PRNewswire/ — VistaGen Therapeutics, Inc., a development stage biopharmaceutical company focused on discovering, developing and commercializing novel small molecule and protein therapeutics for Central Nervous System (CNS) disorders and metabolic diseases using embryonic stem cell … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment